Literature DB >> 31682649

Statement on the Use of Conjugate Pneumococcal Vaccine - 13 Valent in Adults (Pneu-C-13): An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

C Quach-Thanh, Ms H Thomas.   

Abstract

Entities:  

Year:  2013        PMID： 31682649      PMCID： PMC6802426          DOI： 10.14745/ccdr.v39i00a05

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  33 in total

1.  Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.

Authors:  Daniel M Musher; Susan B Manof; Charlie Liss; Richard D McFetridge; Rocio D Marchese; Bonnie Bushnell; Frances Alvarez; Carla Painter; Michael D Blum; Jeffrey L Silber
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

2.  Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients.

Authors:  R F Breiman; D W Keller; M A Phelan; D H Sniadack; D S Stephens; D Rimland; M M Farley; A Schuchat; A L Reingold
Journal:  Arch Intern Med       Date:  2000-09-25

3.  A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.

Authors:  T F Schwarz; J Flamaing; H C Rümke; J Penzes; C Juergens; A Wenz; D Jayawardene; P Giardina; E A Emini; W C Gruber; B Schmoele-Thoma
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

4.  A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.

Authors:  Neil French; Stephen B Gordon; Thandie Mwalukomo; Sarah A White; Gershom Mwafulirwa; Herbert Longwe; Martin Mwaiponya; Eduard E Zijlstra; Malcolm E Molyneux; Charles F Gilks
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

5.  Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults.

Authors:  D R Feikin; C M Elie; M B Goetz; J L Lennox; G M Carlone; S Romero-Steiner; P F Holder; W A O'Brien; C G Whitney; J C Butler; R F Breiman
Journal:  Vaccine       Date:  2001-11-12       Impact factor: 3.641

6.  A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients.

Authors:  Deepali Kumar; Maggie Hong Chen; Brenda Welsh; Deborah Siegal; Isabel Cobos; Hans A Messner; Jeff Lipton; Atul Humar
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

7.  Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.

Authors:  Catherine Cordonnier; Myriam Labopin; Virginie Chesnel; Patricia Ribaud; Rafael De La Camara; Rodrigo Martino; Andrew J Ullmann; Terttu Parkkali; Anna Locasciulli; Karima Yakouben; Karlis Pauksens; Hermann Einsele; Dietger Niederwieser; Jane Apperley; Per Ljungman
Journal:  Clin Infect Dis       Date:  2009-05-15       Impact factor: 9.079

8.  Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation.

Authors:  Deborah C Molrine; Joseph H Antin; Eva C Guinan; Robert J Soiffer; Kristin MacDonald; Richard Malley; Frank Malinoski; Susan Trocciola; Marjorie Wilson; Donna M Ambrosino
Journal:  Blood       Date:  2002-09-19       Impact factor: 22.113

9.  The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study.

Authors:  Reed A C Siemieniuk; Dan B Gregson; M John Gill
Journal:  BMC Infect Dis       Date:  2011-11-11       Impact factor: 3.090

10.  The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004.

Authors:  John D Mooney; Amanda Weir; Jim McMenamin; Lewis D Ritchie; Tatania V Macfarlane; Colin R Simpson; Syed Ahmed; Chris Robertson; Stuart C Clarke
Journal:  BMC Infect Dis       Date:  2008-04-23       Impact factor: 3.090
View more
  4 in total

Review 1.  The role of pharmacists in providing recommended vaccines.

Authors:  Carlene Oleksyn
Journal:  Can Pharm J (Ott)       Date:  2019-10-18

Review 2.  Opportunities for pharmacists in vaccinating higher-risk populations.

Authors:  Carolyn Whiskin; Nora Cutcliffe
Journal:  Can Pharm J (Ott)       Date:  2019-10-16

3.  Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single-dose vaccination strategy for adults in Hong Kong.

Authors:  Jessica J P Shami; Swathi Pathadka; Esther W Chan; Jennifer Hui; Reiko Sato; Shilpa Patil; Xue Li
Journal:  Hum Vaccin Immunother       Date:  2020-01-24       Impact factor: 3.452

4.  Summary of NACI Statement: Interim Recommendations on the Use of Pneumococcal Vaccines in Immunocompetent Adults 65 Years of Age and Older.

Authors:  C Quach; O Baclic
Journal:  Can Commun Dis Rep       Date:  2016-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.